Drug solubilisation and dissolution / bioavailability enhancement

Kuecept's portfolio of drug delivery technologies contain several approaches to enable and improve the bioavailability of drugs with low aqueous solubility or an extreme pH-dependent solubility profile. These technologies have been clinically proven to improve the rate and extent of drug solubilization on a diverse range of compounds with distinctly different physicochemical properties and can result in faster onset of action, improved bioavailability, equivalent therapy at lower doses and/or effective oral dosing of poorly soluble drug candidates.

LenaNano™

  • A rapid and robust particle size reduction technology for preparation of aqueous drug nanosuspensions and fast-dispersing crystalline nano-powders (more)

ProRelease™

  • An amorphous multi-particulate technology for API solubility enhancement and customised release profiles to optimise PK parameters (more)

Solent™

  • An award winning rapid formulation screening service to identify enabling formulations for preclinical efficacy and safety studies. Screens designed for oral and parenteral (IV, SC, IM) dosing (more)

Solumer™

  • A one-step, low-cost spray-drying technology for production of drug-polymer nano-colloids for API solubility and bioavailability enhancement (more)

 

Drug Delivery Technologies